Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, (SEBI LODR Regulations), Fredun Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held today i.e., Friday, July 17 2026, has allotted 11025380 fully paid-up Bonus Equity Shares of the Face Value of ?10 each in the ratio 2:1, i.e., 2 new Bonus Equity Shares of ? 10 each for every 1 existing Equity Share of ? 10 each fully paid- up, held by the shareholders of the Company as on the record date i.e., Thursday, July 16, 2026.
The above information is a part of company's filings submitted to BSE.
